中国医院用药评价与分析2026，Vol.26Issue(3)：380-384,5.DOI:10.14009/j.issn.1672-2124.2026.03.028
头孢比罗酯钠在耐甲氧西林金黄色葡萄球菌血流感染中应用的研究进展
Progress on Application of Ceftobiprole Medocaril Sodium in the Treatment of Blood Stream Infection Induced by Methicillin Resistant Staphylococcus aureus
摘要
Abstract
Blood stream infection induced by multi-drug resistant bacteria is still one of the global public health problems with high incidence rate and mortality.Ceftobiprole medocaril sodium is the fifth generation cephalosporin,which has activity against various Gram-positive including methicillin resistant Staphylococcus aureus and Gram-negative bacteria.Ceftobiprole medocaril sodium is a potential drug for treatment of complex and potentially drug-resistant infections.This article reviews the mechanism of action,antibacterial activity,and clinical application of ceftobiprole medocaril sodium in blood stream infections induced by methicillin resistant S.aureus,providing reference for rational selection and use in clinical practice.关键词
头孢比罗酯钠/耐甲氧西林金黄色葡萄球菌/血流感染/研究进展Key words
Ceftobiprole medocaril sodium/Methicillin resistant Staphylococcus aureus/Blood stream infection/Research progress分类
医药卫生引用本文复制引用
吕鹏,张倩,黄怡菲,张卓..头孢比罗酯钠在耐甲氧西林金黄色葡萄球菌血流感染中应用的研究进展[J].中国医院用药评价与分析,2026,26(3):380-384,5.基金项目
国家卫生健康委医院管理研究所2024年医疗质量(循证)管理研究项目(No.YLZLXZ24G047) （循证）
